Clinical Trial Update: Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for carbogen (carbon dioxide) in the treatment of febrile seizures has terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Seizures

Drugs mentioned

• Carbogen (carbogen)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Febrile Seizure | Phase 2, Phase 3 | Status: TERMINATED